Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system.
D000109:Acetylcholine / Q000032:analysis; D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects*; D002395:Catecholamines / Q000032:analysis*; D004298:Dopamine / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology*; D004347:Drug Interactions; D006321:Heart / Q000187:drug effects; D006900:Hydroxylation; D007275:Injections, Intravenous; D008297:Male; D008526:Medulla Oblongata / Q000032:analysis; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis; D010424:Pentobarbital / Q000494:pharmacology; D011149:Pons / Q000032:analysis; D051381:Rats; D012701:Serotonin / Q000032:analysis; D013997:Time Factors
D000596:Amino Acids; D002395:Catecholamines; D012701:Serotonin; D010424:Pentobarbital; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine